A U.S. Marine Corps MV-22 Osprey lands aboard the Royal Australian Navy landing helicopter dock HMAS Canberra during the Rim of the Pacific exercise in 2022. (Leading Seaman Matthew Lyall/Royal ...
Panelists discuss how implementing interchangeable biosimilars requires effective communication with providers and patients, emphasizing that educating stakeholders before making changes is essential ...
Industry groups and biosimilar manufacturers are seeking explicit guidance from the US Food and Drug Administration (FDA) on interchangeable biosimilar products. The comments were made to the agency ...
Maia Kayal, MD, MS, and Jonathan Kay, MD, define interchangeability and review the details of a switching study. Ryan Haumschild, PharmD, MS, MBA: With all those different options, we know some of the ...
Celltrion said Wednesday that its blood cancer treatment Truxima received interchangeability designation from the US Food and Drug Administration, becoming the ...
When US regulators approved a new drug called Zarxio in March, it became the first FDA-approved biosimilar: a "copy" of a medication made from living things. Drugs derived from biological substances ...
INCHEON, South Korea, May 23, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for YUFLYMA ® ...
ABOARD THE USS ABRAHAM LINCOLN IN THE PACIFIC OCEAN—The U.S. Navy’s top officer is setting a new bar for coalition operations: not just interoperability, but interchangeability. One key to that is ...
As a way to rein in the staggering amount of money that Americans spend on the complex drugs known as biologics each year, creating biosimilars as less-expensive alternatives makes sense. Europe has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results